# Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring <i>c-Kit</i> Mutation or Amplification

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-open-label-single-arm-trial-of-imatinib-mesylate-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jun Guo,Lu Si,Yan Kong,Keith T. Flaherty,Xiaowei Xu,Yanyan Zhu,Christopher L. Corless,Li Li,Haifu Li,Xinan Sheng,Chuanliang Cui,Zhihong Chi,Siming Li,Mei Han,Lili Mao,Xuede Lin,Nan Du,Xiaoshi Zhang,Junling Li,Baocheng Wang,Shukui Qin |
| Citations | 680 |
| DOI | 10.1200/jco.2010.33.9275 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.33.9275?role=tab |
| OpenAlex ID | https://openalex.org/W2096223992 |
| PMID | 21690468 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Junling Li](https://scholariq.org/researchers/junling-li/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)

## Paper topics

- [Mast cells and histamine](https://scholariq.org/topics/mast-cells-and-histamine/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.